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Abstract
The intestinal messenger RNA expression signature is affected by the presence and composition of the endogenous microbiota, with effects on host physiology. The intestine is also
characterized by a distinctive micronome. However, it is not known if microbes also impact
intestinal gene expression epigenetically. We investigated if the murine caecal microRNA
expression signature depends on the presence of the microbiota, and the potential implications of this interaction on intestinal barrier function. Three hundred and thirty four microRNAs were detectable in the caecum of germ-free and conventional male mice and 16
were differentially expressed, with samples from the two groups clustering separately based
on their expression patterns. Through a combination of computational and gene expression
analyses, including the use of our curated list of 527 genes involved in intestinal barrier regulation, 2,755 putative targets of modulated microRNAs were identified, including 34 intestinal barrier-related genes encoding for junctional and mucus layer proteins and involved in
immune regulation. This study shows that the endogenous microbiota influences the caecal
microRNA expression signature, suggesting that microRNA modulation is another mechanism through which commensal bacteria impact the regulation of the barrier function and
intestinal homeostasis. Through microRNAs, the gut microbiota may impinge a much larger
number of genes than expected, particularly in diseases where its composition is altered. In
this perspective, abnormally expressed microRNAs could be considered as novel therapeutic
targets.
Key words: gut microbiota, microRNA, caecum, intestinal barrier, glycosylation, mouse

Introduction
Humans are complex supra-organisms composed of various endosymbionts that stem from all
three domains of life including bacteria, archaea, and

eukarya in addition to their own cells. Body habitats
that are considered “hot spots” for microbial colonization include the skin, oral cavity, gut and urogenital
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tract [1,2]. However, in utero, the fetus is completely
sterile with colonization beginning postnatally. It is
this developmental property that enables for the exploitation of germ-free animals, which are devoid of
microbes on or within their body, in order to determine the functional properties of host endogenous
microbiota.
In fact, the gastrointestinal (GI) tracts of both
humans and conventionally raised mice harbor upwards of 1014 micro-organisms with levels increasing
along the cephalocaudal axis. Temporo-spatially the
organization of bacterial cohorts differs with the
largest densities residing in the large intestine, with
the caecum acting as a fermentation chamber where
upwards of 1011-1012 bacteria/gram luminal contents
ferment otherwise indigestible polysaccharides leading to the production of short chain fatty acids. The
predominant bacteria groups found in human caecal
fluid stems from the E. coli and Lactobacillus-Enterococcus groups that represent 50% of the
caecal bacterial ribosomal Ribonucleic Acid (rRNA)
whereas, Bacteroides (Bacteroides, Porphyromonas and
Prevotella spp.) and Clostridium groups (Clostridium,
Eubacterium and Ruminococcus spp.) represent 13% of
caecal bacterial rRNA [3]. Similarly, the murine caecal
microbiota establishes gradually during early postnatal life, and its complexity increases with age until a
mature community is reached by 4-6 weeks of age
predominately comprising the Bacteroides and Lactobacillus genera and the Clostridium coccoides group [4].
The microbiota residing along the alimentary canal
takes advantage of a continuous supply of nutrients
and optimal temperature while playing a pivotal role
in host physiology, including nutrient processing and
generation, affecting energy homeostasis, education
of the immune system, and fortifying the intestinal
barrier both directly and indirectly [5]. One of the
mechanisms underlying this host-microbe mutualistic
relationship is the reciprocal impact of host and microbial cells on each other’s gene expression programs
[6,7]. In particular, the endogenous microbiota acts as
an environmental factor impacting the expression of
thousands genes in the host epithelium [8,9], and this
is a function of its composition [9,10]. However, the
impact of the microbiota on the intestinal gene expression signature at the messenger RiboNucleic Acid
(mRNA) level may have thus far been under-evaluated due to a lack of studies linking gut microbiota to epigenetic changes in gene expression
particularly, via micro-RiboNucleic Acids (miRNA).
MiRNAs are 20-22 nucleotide, single-stranded,
non-coding
RNA
molecules
involved
in
post-transcriptional gene regulation. Nascent miRNA
exist as large hairpin-loop precursor structures that
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undergo several stages of enzymatic processing. Precursor miRNA molecules are first generated in the
nucleus and then exported into the cytosol where they
are processed by the enzyme Dicer to form shorter
duplexes, with one of the two single-stranded molecules being incorporated as part of the molecular
machinery involved in post-transcriptional gene regulation while the other, passenger strand (usually
indicated with *), is short-lived and rapidly degraded.
The association between the single-stranded miRNA
molecule and the enzymatic complex RNA Induced
Silencing Complex (RISC) lends to translational repression, or cleavage of the targeted mRNA via complementary base pairing to the three prime untranslated region (3’UTR) of their target mRNAs, with the
degree of complementarity dictating the fate of the
target [11]. What has come to light in recent years is
that miRNAs can also induce the up-regulation of
gene expression through interactions with genes that
contain complementary binding sequences in their
promoter regions [12]. To date, 1,048 miRNAs have
been annotated in humans and 672 in mice (miRBase
release 16, 2010) [13] with the true number suggested
to be well over 1,000 miRNAs that are encoded in the
mammalian genome [14]. Indeed, it is estimated that
these short non-coding RNA molecules regulate up to
50% of the transcriptome (protein encoding mRNAs)
[15], however, the true breadth of their potential lies
in the fact that each miRNA can have hundreds of
targets [16] and in retrospect, multiple miRNAs can
have the same mRNA targets. These properties of
miRNAs suggest that a single miRNA can potentially
influence multiple biological pathways [17]. In fact,
miRNAs whose expression is tissue and developmentally regulated [18], have been shown to affect a
broad range of biological processes in plants and
animals including; development, differentiation, cell
proliferation, apoptosis [19], regulation of innate
immunity [20] and defense from viruses and pathogens [21,22].
Whilst few studies have investigated the mammalian intestinal miRNA signature, a recent analysis
of the global porcine micronome demonstrated the
expression of 332 miRNAs along the intestinal tract
with region-specific expression along the longitudinal
gut axis [23]. In line with these findings, upwards of
200 known mature miRNAs and 122 miRNA* species
were identified in colorectal cell lines [24] with some
found in following clinical studies to have a greater
affinity for expression in specific regions and most
expressed globally in the human GI tract [25]. Intestinal miRNAs have experimentally proven biological
roles ranging from the regulation of neonatal nutrient
metabolism [26] to the control of intestinal fluid and
http://www.biolsci.org
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electrolyte transport [27] and permeability [28], besides affecting intestinal epithelial cell differentiation
[29] and maturation [30].
The intestinal miRNA signature has been found
to be deregulated in various disease states. MiRNAs
can display both oncogenic or tumor suppressive effects in several types of cancers [31], and recently 11
miRNAs were found to be differentially expressed in
the sigmoid colon of patients with active ulcerative
colitis (UC) versus healthy controls [32], with effects
on secretion of pro-inflammatory chemokines [32].
In addition, both plants and animals differentially express miRNAs following sensing of pathogen-associated molecular patterns (PAMPs). For instance, bacterial flagellin-induced upregulation of
miR-393 in Arabidopsis thaliana participates in the regulation of the host defense system [22]. In animals,
specific miRNAs are induced in response to various
bacterial components, such as lipopolysaccharide
(LPS) in monocytes [33] and to viral infection such as
in Hepatitis B and C [34]. Moreover, miR-155 is upregulated in gastric epithelial cells following Helicobacter pylori infection [35]. All of these changes resulted in downstream regulation of the immune response.
It has been recently suggested that the onset of
several intestinal diseases including Inflammatory
Bowel Disease (IBD) and Irritable Bowel Syndrome
(IBS), are caused by both deregulation of the intestinal
barrier function and by microbial factors [36,37], but
how the two intertwine to affect such conditions is not
well understood. The intestinal barrier is a multi-tiered line of defense localized at the interface between the external environment and internal milieu
and comprises physical, chemical and receptor-mediated pathogen sensing components [38]. The
endogenous gut microbiota is an important constituent of the barrier in that it not only participates in the
formation of the physical and chemical barrier via
pathogen exclusion, antimicrobial peptide secretion,
and immuno-modulation, but also acts as a vector of
change by modulating the mRNA expression of a
number of genes involved in intestinal barrier function [9,7]. However, the epigenetic basis of these interactions is yet to be elucidated as there is a lack of
studies evaluating modulation of host miRNAs in
response to symbiotic microorganisms. Intriguingly,
legumes miRNAs are modulated during the establishment and maintenance of the rhizobia symbiosis
in root nodules [39]. Though, it is unknown if this is
also true for animals who live in a symbiotic relationship with complex microbial communities at various body sites such as the intestine.
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We used germ-free and conventionally raised
mice to investigate the impact of the endogenous microbiota on the global expression of caecal miRNAs in
vivo. We show that the murine miRNA signature in
the caecum is comprised of several variously expressed species and that it is indeed affected by the
presence of the microbiota. Moreover, we show that
several of the putative mRNA targets of the modulated miRNAs encode for genes known to be involved
in the regulation of the intestinal barrier function,
including glycosylation enzymes, junctional proteins,
proteins found in the mucus layers and genes involved in immune regulation.

Materials and Methods
Animals
Swiss Webster male mice were used according to
the Regulations of the Animals for Research Act in
Ontario and the Guidelines of the Canadian Council
on Animal Care. Animal study design and procedures
were approved by the animal ethics committee at the
University of Toronto (Animal Use Protocol Number:
20008318). Five germ-free and five conventionally
raised mice, 6 weeks of age, were obtained from Taconic Farms (Germantown, NY), sacrificed via cervical dislocation and then dissected in sterile conditions.
Upon sacrifice, the entire caecum was immediately
excised and caecal contents were collected. Caecal
tissues were further cleaned with sterile 0.9 % NaCl,
divided into two halves longitudinally, snap-frozen in
liquid nitrogen and stored at -80°C until further processing. Caecal contents were immediately fixed in 4%
paraformaldehyde and used to confirm the germ-free
status of the animals by Fluorescence in situ Hybridization with the EUB338 5’-Cy3 labeled 16S rRNA
probe specific for all bacteria (5’/5Cy3/GCT GCC
TCC CGT AGG AGT-3’) (Integrated DNA Technologies), as previously described [40].

RNA extraction
Small RNA-containing total RNA was extracted
from one-half segment of the caecum from both
germ-free (n = 5) and conventionally-raised (n = 5)
mice, using miRVANATM miRNA Isolation Kit (Ambion, Austin, TX, USA), as per the manufacturer’s
instructions, eluted in 100 µl of RNAse-free water and
stored at -80°C. Recovered total RNA concentration
and purity were spectrophotometrically assessed using Thermoscientific’s Nanodrop 1000 Spectrophotometer (Nanodrop Technologies, Wilmington, DE,
USA) and ranged between 2.13-2.16 and 2.01-2.12,
respectively. RNA integrity was confirmed by denaturing agarose gel electrophoresis.

http://www.biolsci.org
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Global microRNA expression profiling
cDNA was synthesized from 1 µg of total RNA
(n = 3 per group) using the Taqman® MicroRNA Reverse Transcription Kit in conjunction with Rodent
Megaplex™ Primer Pools according to the manufacturer’s protocol (Applied Biosystems, CA, USA). The
Rodent Megaplex™ Primer Pools contains two sets of
microRNA-specific RT primers, pools A and B, that
enable for the RT of 375 microRNAs/6 species-specific controls and 210 microRNAs/6 species-specific controls, respectively. Separate reactions
were run for pools A and B in Applied Biosystems’
GeneAmp® PCR System 2700 Thermocycler. Global
microRNA expression profiling was conducted by
TaqMan quantitative PCR using Applied Biosystems’
Taqman® Rodent MicroRNA Array Set v2.0 (Taqman
Low Density Arrays, TLDAs) that comprise two microfluidic cards (plates A and B) containing a total of
384 Taqman® Assays per card (some of which are
duplicate probes). cDNA products from the Megaplex
RT pools set were independently assessed on both
microfludic cards with plate A enabling for the simultaneous quantification of 375 microRNA targets/6
controls while plate B, 210 microRNA targets/6 controls. The protocol suggested by the manufacturer
was followed. Real-Time PCR was performed using
an Applied Biosystems 7900 HT Real-Time PCR system and default thermal-cycling conditions for
384-wells Taqman Low Density Arrays.

Real-Time PCR validation of individual microRNAs expression
Ten ng of total RNA (n=5 per group) was reverse
transcribed with the Taqman® MicroRNA Reverse
Transcription Kit and primers specific for miR-455
(Assay ID: 002455) and the endogenous control
snoRNA135 genes (Assay ID: 001230) (Applied Biosystems) in Applied Biosystems’ GeneAmp® PCR
System 2700 Thermocycler according to the manufacturer’s protocol. Real time PCR was then conducted using undiluted cDNA, TaqMan MicroRNA
Assays (miR-455 assay ID: 002455 and snoRNA135
assay ID: 001230) and the TaqMan 2X Universal PCR
Master Mix, No AmpEraseUNGa (Applied Biosystems) in a 10 µl PCR reaction. Each reaction was run in
triplicates in a 384-well optical plate in Applied Biosystems’ 7900 HT Real-Time PCR machine using the
9600 emulation mode with an initial hold at 95°C for
10 minutes followed by 40 cycles of 95°C for 15 seconds, and 60°C for 60 seconds. Results were expressed as fold change between germ-free and conventional mice as calculated by ΔΔCt method [41]
after normalization to sno-135 gene, which was
shown to be equally expressed in the caeca of the two
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groups of mice by the TLDA experiments. Significance of differential gene expression was assessed
with the Mann-Whitney test using GraphPad Prism 5
Software (La Jolla, CA, USA).

Analysis of TLDA data
Raw data were pre-processed in SDS 2.3 for individual plates and then concurrently for all plates in
SDS RQ Manager 1.2 (Applied Biosystems) for the
generation of Ct (Cycle threshold) values. A
pre-selection filter was applied to all miRNA TLDA
data to reduce noise in the dataset and to reduce the
severity of the multiple testing adjustment. To this
end, any miRNA not meeting both of the following
criteria were removed from further analysis: a) Presence in all three of either conventional samples or the
germ-free group; b) Presence in at least one of the
conventional samples to enable the ΔΔCt method to
be used for normalization. Following pre-filtering, all
duplicate probes for the same miRNA species on the
same plate were averaged and the mean Ct value was
utilized for further analysis. Data were then normalized by “columnwise mean” normalization, such that
the target miRNA is normalized to the mean Ct of all
miRNA for each sample, a method that has been
suggested as an improvement for high-throughput
miRNA Quantitative PCR (qPCR) [42] where the
mean abundance of hundreds of targets may be more
stable than any endogenous control across samples
and experimental groups. To identify differentially
expressed genes, the empirical Bayes-moderate t-test
was used as implemented in the LIMMA R package
[43]. For this approach, missing Ct values were assumed to be unknown rather than imputed to 40, to
avoid creating a bimodal distribution of Ct values,
which would violate the assumption of the t-test.
False discovery rate was calculated by the method of
Benjamini and Hochberg, as implemented in the R
package multtest (Pollard et al., v.1.22.0). Supervised
heatmaps were created using the R package gplots.
Clustering in the heatmaps is based on complete
linkage and Euclidean as the distance metric, using
default setting for the hclust (hierarchical cluster)
function in R [44].
Analysis was performed in the R language and
environment for statistical computing (R Development Core Team, 2008, v2.8.1) [45].

MiRNAs target prediction
To investigate the relationship between selected
miRNAs of interest and the genes that they potentially target, we mapped them into a miRNA network
using NAViGaTOR ver. 2.2 [46]. We first used high
precision miRNA:target relationships in mouse http://www.biolsci.org
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taken from the TargetScan Conserved Targets (Conserved_Sites_Context_Scores.txt
Release
5.1)
[47,48,49] or PITA TOP database predictions
(PITA_targets_mm9_0_0_TOP.tab.gz,
May
2010
download) [50]. Previous work examining miRNA:target relationships suggests that both PITA and
TargetScan provide high quality interactions suitable
for the construction of an interaction network [51].
Genes identified by this first analysis were then filtered based on their inclusion in an intestinal barrier
gene set to assess the potential impact of differentially
expressed miRNAs on the intestinal barrier function.
A subset of 527 genes important in maintenance of the
intestinal barrier function were identified and classified according to function - mainly physical, chemical
and pathogen sensing components as per Cummings
J. H., et al. [38] (Additional file 5: Table S5). Identified
miRNA target genes were filtered by the intestinal
barrier set prior to being mapped into the miRNA
network. This reduced the number of initial miRNA
target genes of the 11 miRNAs with predicted targets
from 2,755 in the general setting to 34 present in the
intestinal barrier setting.

Analysis of miRNA potential targets biological
function
To further understand the functions of gene targets of miRNAs with altered expression in this study,
we examined all 2,755 gene targets of the 11 miRNAs
prior to the filtering step. Using the Panther Classifi-
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cation System Version 7.0 [52,53], we examined the
over- or under- representation of our miRNA target
genes compared to a universe consisting of all genes
listed as miRNA targets in the PITA Top Targets or
TargetScan Conserved Targets (as discussed above).
Categories examined include Gene Ontology Classes:
Biological Processes, Molecular Function, Cellular
Component as well as Pathway Analysis and Protein
Class Analysis.

Results
Differential expression of miRNAs in the caecum of germ-free and conventionally raised
mice
To assess if the caecal miRNA expression signature is associated with the presence of the endogenous
microbiota, we examined small RNA-containing total
RNA extracted from the caecum of germ-free (n=3)
and conventionally raised mice (n=3). Each sample
was independently run on two different Taqman Low
Density Arrays (Plates A and B), which combined
allow for the analysis of 585 mature miRNAs. Fifty-seven percent of the targeted miRNAs were detectable (Ct<35) in the caeca of both germ-free and
conventionally raised mice (Additional file 1: Table
S1). Ranked mean abundance of miRNAs was similar
for both groups of mice (Spearman R=0.74, P< 0.0001,
95% CI= 0.68 to 0.78) (Figure 1).

Figure 1. Caecal global microRNA expression is correlated in germ-free and conventional mice. Scatter plot depicting the
relationship between global miRNA expression levels of 336 miRNAs in germ-free (GF) and conventional (Conv) caecal samples
(n=3/group) as assessed by qRT-PCR and TLDA plates A and B. Data are presented as mean delta Ct values for each miRNA (mean delta
Cts represent the average delta Ct for all three samples/group, with each individual Ct normalized by mean expression value normalization
procedure). Of the 585 miRNA species analyzed, 336 remained after filtering and normalization, as explained in Materials and Methods and
were used in subsequent analyses.

http://www.biolsci.org
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We found 18 transcripts differentially expressed
between the two groups, including both up- and
down-regulated miRNAs with a fold change
(germ-free vs. conventional) ranging between 0.2 and
4.6 (Table 1) (False Discovery Rate = 0.2). These correspond to 16 unique miRNAs, including
mmu-miR-351 and rno-miR-351 - two sequences conserved in mouse and rat - while Y1 is a rat endogenous small RNA. A second rat miRNA species,
rno-miR-664, was found to be significantly
up-regulated by 2.85-fold in germ-free samples. The
murine homolog, mmu-miR-664, is not represented
on the TLDA plates that we used. Sequence analysis
using miRviewer [54] demonstrates that miR-664-1

shows sequence similarity in rat, mouse and horse
with a greater conservation amongst rat and mouse.
Therefore, it is likely that the measured signal is biologically reliable and derives from cross-reaction of
the rno-miR-664 TaqMan assay with the homologous
murine miRNA species. Five of the sixteen transcripts
correspond to passenger miRNA (miRNA*) sequences. Up-regulation of miR-455 in germ-free versus
conventional mice was confirmed in a separate experiment using gene-specific single-well TaqMan PCR
and RNA from the caecum of five mice per group
(fold change germ-free versus conventional=1.7,
Mann-Whitney test p=0.0079).

Table 1. Differentially expressed microRNA in germ-free versus conventional mice. Real-time PCR analysis of the global
expression of microRNAs in the caecum of germ-free (GF) (n=3) versus conventional (CONV) mice (n=3). Fold-change and statistical
significance were calculated after mean expression value normalization. Statistical significance is based on Bayes-moderated t-test with a
FDR of 20%. In total 18 transcripts were found to be differentially expressed between the two groups with 16 unique mature microRNAs
(Y1 is a rat endogenous small RNA). Fold change corresponds to the ratio of mean expression of the microRNA in GF mice to mean
expression in CONV mice. Values < 1 indicate lower expression in GF (down-regulated in GF mice compared to CONV mice), whereas
values > 1 indicate higher expression in GF (up-regulated in GF mice compared to CONV mice). Genomic locations and corresponding
microRNA sequences (5’ – 3’) are based on miRBase version 16. Homology of microRNA sequences between diverse species is derived
from miRviewer (last updated November 9, 2008).
miRNA
mmu-miR-21*

Fold Adjusted Genomic Location
GF vs. P-values
Conv
0.20
0.06
chr11: 86397569-86397660 [-]

Mature miRNA Sequence
(5’ – 3’)

Homology

rno-miR-351

0.31

0.06

chrX: 139999130-139999210 [-] 16 -UCCCUGAGGAGCCCUUUGAGCCUGA- 40 Mmu, Rno

56 -CAACAGCAGUCGAUGGGCUGUC - 77

NA

mmu-miR-351

0.33

0.20

chrX: 50406432-50406530 [-]

16 -UCCCUGAGGAGCCCUUUGAGCCUG- 39

Mmu, Rno

mmu-miR-487b

0.45

0.12

50 -AAUCGUACAGGGUCAUCCACUU- 71

mmu-miR-467a -1 0.47
mmu-miR-467a -2
mmu-miR-467a -3
mmu-miR-467a -4
mmu-miR-467a -5
mmu-miR-467a -6
mmu-miR-467a -7
mmu-miR-467a -8
mmu-miR-467a -9
mmu-miR-467a -10
mmu-miR-27b*
0.54

0.06

Mmu, Rno, Hsa, Ptr, Mml,
Str, Bta, Laf
Mmu

0.16

chr12: 110965543-110965624
[+]
chr2: 10397973-10398045 [+]
chr2: 10400425-10400507 [+]
chr2: 10405305-10405387 [+]
chr2: 10407762-10407844 [+]
chr2: 10410226-10410308 [+]
chr2: 10412675-10412757 [+]
chr2: 10415137-10415219 [+]
chr2: 10417607-10417689 [+]
chr2: 10420020-10420102 [+]
chr2: 10424900-10424982 [+]
chr13: 63402020-63402092 [+]

7 -AGAGCUUAGCUGAUUGGUGAAC- 28

NA

mmu-miR-148a

0.58

0.12

chr6: 51219811-51219909 [-]

61 -UCAGUGCACUACAGAACUUUGU- 82

mmu-miR-145

1.52

0.17

chr18: 61807479-61807548 [-]

7 -GUCCAGUUUUCCCAGGAAUCCCU - 29

mmu-miR-183

1.56

0.17

chr6: 30119668-30119737 [-]

6 -UAUGGCACUGGUAGAAUUCACU- 27

mmu-miR-133a -1
mmu-miR-133a-2

1.61

0.12

chr18: 10782907-10782974 [-] 43 -UUUGGUCCCCUUCAACCAGCUG- 64
chr2: 180133084-180133187 [+] 59 -UUUGGUCCCCUUCAACCAGCUG- 80

Mmu, Hsa, Ptr, Ppy, Mml,
Oga, Cpo, Ocu, Opr, Bta,
Cfa, Eca, Eeu, Fca, Laf, Tbe,
Mlu, Mdo, Gga, Xtr
Mmu, Rno, Hsa, Ptr, Ppy,
Mml, Mim, Oga, Cpo,
Ocu, Opr, Sar, Str, Bta,
Cfa, Dno, Eca, Eeu, Ete,
Fca, Tbe, Mlu, Mdo, Oan,
Dre, Gac, Tru, Xtr
Mmu, Rno, ,Hsa, Ptr, Ppy,
Mml, Mim, Oga, Opr, Sar,
Str, Bta, Cfa, Dno, Eca,
Ete, Fca, Tbe, Mlu, Mdo,
Oan, Gga, Dre, Gac, Ola,
Tni, Tru, Xtr, Cin
miR-133a-1: Mmu, Hsa,
Ptr, Cpo, Ocu, Opr, Sar,
Str, Bta, Cfa, Dno, Eca,
Eeu, Ete, Fca, Tbe, Gga,
Dre, Gac, Ola, Tru

10 -UAAGUGCCUGCAUGUAUAUGCG- 31
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36
15 -UAAGUGCCUGCAUGUAUAUGCG- 36

http://www.biolsci.org
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miR-133a-2: Mmu, Hsa,
Ptr, Gga, Dre
Mmu, Rno, Hsa, Ptr, Ppy,
Mml, Mim, Opr, Sar, Str,
Bta, Cfa, Eca, Fca, Tbe,
Oan, Dre, Ola, Xtr
NA

mmu-miR-150

1.66

0.15

chr7: 52377127-52377191 [+]

6 -UCUCCCAACCCUUGUACCAGUG- 27

Y1-4386739.B

2.02

0.15

NA

NA

mmu-miR-672

2.74

0.06

chrX: 101311514-101311613 [-] 25 -UGAGGUUGGUGUACUGUGUGUGA- 47

mmu-miR-181a-1*

2.79

0.17

chr1: 139863032-139863118 [+] 54 -ACCAUCGACCGUUGAUUGUACC- 75

rno-miR-664 -1
rno-miR-664-2

2.85

0.06

mmu-miR-455

3.00

0.15

chr18: 47881354-47881412 [+]
chr13: 101253993-101254051
[+]
chr4: 62917885-62917966 [+]

mmu-miR-138*

4.43

0.12

chr9: 122591994-122592092 [+] 61 -CGGCUACUUCACAACACCAGGG- 82

miR-664-1: Mmu, Rno,
Eca
miR-664-2: Rno, Laf
Mmu, Rno, Hsa, Ptr, Ppy,
Mml, Mim, Oga, Cpo,
Ocu, Opr, Str, Bta, Cfa,
Eeu, Ete, Fca, Laf, Mlu,
Mdo, Gga, Dre, Gac, Ola,
Tni, Tru, Xtr
NA

mmu-let-7g*

4.60

0.10

chr9: 106081171-106081258 [+] 63 -ACUGUACAGGCCACUGCCUUGC- 84

NA

Analysis of miRNA conservation and their genomic contexts revealed that all of the significantly
differently expressed miRNAs belong to various families and cluster separately in terms of their genomic
locations with the exception of miR-351 in which both
rat miRNA (rno-miR-351), and murine miRNA
(mmu-miR-351) were found to belong to the same
mir-351 family, based on sequence conservation [13].
Furthermore, supervised hierarchical clustering
analysis using the 18 differentially expressed transcripts demonstrated intra-group similarities in
miRNA expression with inter-group variation in
miRNA expression (Figure 2), showing that the caecal
miRNA signatures cluster according to the presence
or absence of the endogenous microbiota.

Experimentally verified and predicted mRNA
targets of the differentially expressed miRNAs
Based on Tarbase V5.0 [55] and miRecords V2.0
[56], two freely available databases that provide a
repository of information pertaining to experimentally validated miRNA targets in several animal species, plants and viruses, six (miR-133a, miR-672,
miR-183, miR-148a, miR-145, miR-150) of the sixteen
differentially expressed miRNAs have experimentally
verified mRNA targets (Additional file 2: Table S2). Of
these mRNA targets, seven (Serum response factor
(Srf), Ras homolog gene family, member A (Rhoa), Cell
division cycle 42 homolog (S. cerevisiae) (Cdc42),
Peroxiredoxin 6 (PRDX6), Homeo box A9 (Hoxa9),
Vascular endothelial growth factor A (Vegfa), and
Myeloblastosis oncogene (Myb) were detected with a
signal intensity higher than 150 in microarray experiments analyzing gene expression in C57BL/6

38 -UAUUCAUUUACUCCCCAGCCUA- 59
38 -UAUUCAUUUACUCCCCAGCCUA- 59
54 -GCAGUCCACGGGCAUAUACAC- 74

Mmu, Rno, Mim, Oga,
Cpo, Ocu, Str, Dno, Eca,
Ete, Cin
NA

mice caeca (n=2) (Gene Expression Omnibus [57] dataset GSE1133 [58]). Therefore, based on the miRNA/mRNA co-expression criterion for target validation [59], these genes are good candidates for microbiota-dependent expression modulation via miRNA.
However, each miRNA species is likely to have
multiple physiologically relevant targets, most of
which are unknown, and several algorithms can be
employed for their in silico identification. To predict
targets for the 16 miRNAs found to be differentially
expressed between germ-free and conventional mice,
we adopted a conservative approach. We extracted
target predictions from 2 sources: Probability of Interaction by Target Accessibility (PITA) [50] and TargetScan [47,48,49]; thus, our target prediction sets are
based on several criteria including conservation of
target binding sites and the degree of accessibility of
the three prime untranslated regions of the mRNA
target. Two thousand seven hundred and fifty-five
unique genes were found to map as targets of these
miRNAs as predicted by both algorithms (Additional
file 3: Table S3). These genes were mapped to
PANTHER database [52] to assess their group descriptors. We first considered the Gene Ontology
classifications and found our gene list to be significantly enriched in several categories: (1) biological
processes including development, cell communication, signal transduction (all at p<0.0001), among
others; (2) molecular functions including DNA, transcription factor, protein binding (all at p<0.0001),
among others; and (3) cellular components such as
actin cytoskeleton (p<0.0001) (Additional file 4: Table
S4). Next, we found our targets enriched in the Wnt
signaling pathway, angiogenesis, transforming
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growth factor-beta (TGF-β) and cadherin signaling
pathways and in the transcription factors protein class
followed by enzyme modulator and ribosomal proteins (all at p<0.0001), among others (Additional file 4:
Table S4). Several of the 2,755 global putative targets
of the differentially expressed miRNAs were found to
map to diverse components of the intestinal barrier
function when assessing gene ontologies. These include; (1) Biological Processes such as cell-cell adhesion (p<0.0001), immune system processes (p<0.001)
encompassing antigen processing and presentation
(p<0.01) and defense response to bacterium (p<0.2)
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amongst others; (2) Molecular Functions including
structural constituents of cytoskeleton (p<0.0001) and
(3) Cellular Components such as actin cytoskeleton
(p<0.0001), MHC protein complex (p<0.01), cell junction (p<0.01) as well as other factors (Additional file 4:
Table S4). Similarly, identification of the inflammation
mediated by chemokine and cytokine signaling
pathway (p<0.001) during functional analysis of in
silico data demonstrate potential implications of microbial-dependent miRNA regulation on the intestinal
barrier function.

Figure 2. Clustering of caecal microRNAs expression profiles in germ-free and conventionally raised mice. The profiles of
18 transcripts including 16 microRNAs significantly differently expressed (p<0.05, FDR<20%) between germ-free and conventional caecal
samples were visualized using a supervised heatmap (complete linkage and Euclidean distance metric). Expression values range from +2.5
log2 to -2.5 log2 of ∆Ct values normalized using mean expression value normalization with positive values (red) indicating higher expression and negative values (green) indicating lower expression in germ-free versus conventional mice. Dendrograms indicate the
correlation between groups of samples and genes. Samples are in columns and transcripts in rows.
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MiRNA-dependent regulation of the intestinal
barrier function by the endogenous microbiota
Considering the results described above, and the
fact that endogenous microbes play an important role
in the creation and maintenance of the intestinal barrier we decided to investigate the potential impact of
the microbiota-responsive miRNAs on the intestinal
barrier function via analysis of intestinal barrier specific gene targets. We first compiled a gene set containing 527 genes involved in the regulation of the
intestinal barrier function, as explained in Materials
and Methods, which we called the “Intestinal Barrier
Gene Set”. The list of genes included in this gene set is
provided as (Additional file 5: Table S5). We then filtered the 2,755 target genes by this pre-defined gene
set and established all miRNA:target interactions for
the remaining genes. Using NAViGaTOR (Network
Analysis, Visualization and Graphing Toronto) ver.
2.2 [46], a scalable, network analysis and visualization
system, we mapped the miRNA network linking our
identified miRNA of interest in order to examine the
micronome, as described before [51] (Figure 3).
miR-487b did not have any intestinal barrier targets as
per the algorithms employed and therefore it does not
appear in the figure. Thirty-four intestinal barrier-related genes were found to be among the potential
targets of the intestinal miRNAs the expression of
which depends on the endogenous microbiota, and
fifteen of these were identified by both algorithms.
These include genes involved in glycosylation,
cell-cell junction formation, the mucus layer and
genes involved in immune regulation particularly
MHC I and II proteins amongst others. Closer inspection of this miRNA interaction network reveals several genes co-targeted by the miRNAs identified as
differentially expressed between the caecal miRNA
signatures in germ-free and conventional mice. Formin 1 (FMN1) is co-targeted by 2 miRNAs
down-regulated in the germ-free mice (miR-351 and
miR-467a) as well as one up-regulated miRNA
(miR-145). Other genes appearing to be co-targeted by
multiple differentially expressed miRNAs are: Cadherin 5 (Cdh5), UDP-N-acetyl-alpha-D-galactosamine:
polypeptide N-acetylgalactosaminyltransferase 5
(Galnt5), poliovirus receptor-related 1 (Pvrl1), fascin
homolog 1, actin bundling protein (Fscn1), Cingulin
(Cgn), glucosaminyl (N-acetyl) transferase 1, core 2
(Gcnt1) and UDP-N-acetyl-alpha-D-galactosamine:
polypeptide N-acetylgalactosaminyltransferase 7
(Galnt7). Of the thirty-four predicted intestinal barrier
genes targets, twenty had been previously found to be
expressed in the caeca of C57BL/6 mice (n=2), in microarray experiments with a hybridization signal
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higher than 150 (ATP-binding cassette, sub-family B
(MDR/TAP) member 9 (Abcb9), Nicastrin (Ncstn),
Spermidine/spermine N1-acetyl transferase 1 (Sat1),
Desmoglein 3 (Dsg3), UDP-Gal:betaGlcNAc beta 1,4galactosyltransferase, polypeptide 1 (B4galt1), Leucine
aminopeptidase 3 (Lap3), beta-1,3-galactosyl-Oglycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (Gcnt1), CMP-N-acetylneuraminate-beta1,4-galactoside alpha-2,3-sialyltransferase (St3gal3),
Junction plakoglobin (Jup), Aminopeptidase puromycin sensitive (Npepps), UDP-N-acetyl-alpha-Dgalactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (Galnt7), Plakophilin 1 (Pkp1), (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-a
cetylgalactosaminide alpha-2,6-sialyltransferase 6
(St6galnac6), Carcinoembryonic antigen-related cell
adhesion molecule 1 (Ceacam1), Formin-1 (Fmn1),
Prostasin (Prss8), glycoprotein-N-acetylgalactosamine
3-beta-galactosyltransferase
1
(C1galt1),
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase,
polypeptide 5 (B4galt5), UDP-Gal:betaGlcNAc beta
1,4- galactosyltransferase, polypeptide 2 (B4galt2),
Myosin, light polypeptide kinase (Mylk) (Gene Expression Omnibus [57] dataset GSE1133 [58]). This list
is conservative, since not all of the genes shown in
Figure 3 had microarray probes.
Seventy one percent of the genes included in our
gene set were not considered by PITA and TargetScan
due to the low conservation of the 3’UTR in homologous genes. Moreover, this analysis did not incorporate passenger miRNAs because they are not considered in PITA and TargetScan databases. Alternatively,
when using MicroCosm targets [13] to map these,
only miR-let7g* had targets remaining after filtering
with the intestinal barrier gene set. These are:
C1GALT1-specific chaperone 1 (C1galt1c1), Claudin-7
(Cldn7), Histocompatibility 2, class II antigen A, beta 1
(H2-Ab1), Pancreatitis-associated protein (Pap),
Phospholipase A2, group XIIA (Pla2g12a), Phospholipase A2, group IB (Pla2g1b), Spermidine synthase
(Srm), Thimet oligopeptidase 1 (Thop1), Toll-like receptor-11 (Tlr11) and Toll-like receptor-13 (Tlr13).
Finally, in order to substantiate the hypothesis
that gut commensals impact the intestinal barrier via
miRNA expression modulation, we crossed-matched
our global list of intestinal barrier genes with genes
previously identified to be differentially expressed in
the jejunal mucosa of intestinal-specific Dicer
knock-out mice [60]. The result of this analysis provides experimental evidence that miRNAs indeed
impact on barrier-related gene expression, with potential repercussions on its function. Of particular
interest are intestinal barrier genes from our list that
were found to be experimentally perturbed (up- or
http://www.biolsci.org
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down-regulated) by the conditional knock-out of
Dicer [60]. They include: glycosylation enzymes, immuno-inflammatory response genes, components of
MHC I and II, junctional proteins, mucus layer associated proteins and defense response proteins, including antimicrobial peptides and Pathogen Associated Molecular Pattern (PAMP) responsive elements.
Although, this analysis shows that miRNAs affect
genes that comprise the intestinal barrier, in order to
further establish a nexus between microbial induced
modulation of miRNAs, which in turn affects barrier
function, we combined putative barrier related gene
targets of the microbial dependent miRNAs (Figure 3)
with the Dicer knock-out mice data [60]. Among the
genes differentially expressed in the absence of
miRNAs in the jejunal mucosa, we found that seven
intestinal barrier related genes were either
up-regulated
(glycoprotein-N-acetylgalactosamine
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3-beta-galactosyltransferase 1 (C1galt1), myosin, light
polypeptide kinase (Mylk), Aminopeptidase puromycin sensitive (Npepps), UDP-N-acetyl-alpha-Dgalactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (Galnt7) and Prostasin (Prss8)), or
down-regulated (protein kinase C zeta isoform a
(Prkcz), beta-1,3-galactosyl-O-glycosyl-glycoprotein
beta-1,6-N-acetylglucosaminyltransferase
(Gcnt1)).
More specifically, since these seven genes are in silico
targets of the miRNAs modulated by the absence or
presence of the microbiota (germ-free versus conventional mice) and experimental evidence points to a
role of epigenetic regulation of these genes via miRNAs (Dicer knock-out study) it reiterates a potential
novel mechanism of host-microbial cross-talk via microbial dependent regulation of miRNAs that may
translate into effects on the host with respect to regulation of the intestinal barrier function.

Figure 3. Differentially expressed microRNAs impact on the intestinal barrier. MicroRNAs significantly differentially expressed between germ-free and conventional mice are represented in this diagram by circles, with the colour corresponding to degree of
differential microRNA expression in germ-free and conventional samples. Expression values range from +2.5 log2 to -2.5 log2 of ∆Ct values
with positive values (red) indicating higher expression, and negative values (green), indicating lower expression in germ-free versus
conventional mice. Putative intestinal barrier gene targets as identified by the algorithms TargetScan and PITA are represented by triangles. MicroRNAs with a greater number of intestinal barrier targets are symbolized with a larger circle size. Intestinal barrier gene
targets that are predicted by both algorithms are indicated by thicker lines. Differentially expressed microRNAs* were not included in the
diagram as they are not present in both prediction databases. miR-487b did not have any intestinal barrier targets as per the algorithms and
therefore was excluded from the figure.
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Discussion
Gene expression modulation is one of the
mechanisms underlying the cross-talk between gut
endogenous microbiota and host epithelium, and
therefore plays a critical role in intestinal homeostasis.
Here we show that the presence of the microbiota in
the murine intestinal tract, particularly in the caecum,
also associates with a distinctive miRNA signature,
supporting a role for gut endosymbionts in
post-transcriptional regulation of gene expression.
Few studies have looked at the relative expression of
miRNAs along the cephalocaudal axis of the healthy
gut, particularly with respect to the passenger miRNA* forms, and to the best of our knowledge, this is
the first study examining miRNA expression in the
murine caecum. We found a characteristic micronome
in the caecum, with 334 miRNA species expressed in
this region in both germ-free and conventional mice;
of these, 74 are miRNA* forms. While miRNAs* are
thought to correspond to the rapidly degraded strand
of the miRNA duplex, there is evidence suggesting
that they may play a so-far unrecognized role within
cells [24], and in fact may act in a similar fashion to
guide strand miRNAs in terms of abundance and
gene regulation [61].
Comparison of the global murine miRNA signature along several intestinal loci, namely the small
and large intestinal mucosa, as well as our caecal
analysis allows for certain parallels to be drawn. Some
of the miRNAs belonging to the 15 miRNAs/miRNA
families most expressed in the jejunal and colonic
mucosa [60] are also expressed in the caeca of both
germ-free and conventional mice (Additional file 6:
Table S6) and 3 (miR-192, miR-378, miR-29a) of the 15
miRNAs most highly expressed (based on Ct values)
in the caecum are also expressed in both the jejunum
and colon [60]. Although diverse genes cannot be
compared by Ct values, sorting allows for a qualitative measure of the relative level of gene expression
and to identify genes that do or do not display a regional expression pattern within the intestine.
miR-143 and miR-145 were part of the top expressed
miRNAs in common between the jejunum and caecum, and are found in the same genomic cluster
(<10kb distance from one another on chromosome 18).
miR-200b was found in common as a highly expressed miRNA within both the large intestine and
caecum. Interestingly, other miRNAs with sequence
similarities to miR-200b were also found to be highly
expressed, including miR-200a in the colon, and
miR-200c in the caecum, suggesting that members of
the miR-8 family play an important physiological role
in distal intestinal regions. On the other hand, 19
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miRNAs were found to be expressed in the caecum of
conventional mice (Ct<35) but not in the jejunal or
colonic mucosa based on the absence of sequence read
data [60] in either of the two regions (Additional file 6:
Table S6), suggesting they may be restricted to the
caecum. Intergroup comparisons between germ-free
and conventional mice illustrate a relatively high degree of similarity between the top miRNAs expressed
in germ-free and conventional caeca with all 15 of the
miRNAs with the lowest Ct values overlapping between the two groups (Additional file 6: Table S6).
Moreover, there is a general concordance between the
murine caecal micronome and the human intestinal
micronome, which incorporates the caecum. Juxtaposing data on the 13 most highly constitutively expressed miRNAs in both the terminal ileum and colon
(caecum, transverse colon, sigmoid colon and rectum)
from pinch biopsy samples of healthy adults [25] with
the murine caecal miRNA signature of conventional
and germ-free mice, revealed that, five miRNAs
(miR-143, miR-192, miR-200b, miR-200c and miR-24)
found in the intestines of humans were amongst the
top 15 mostly highly expressed miRNAs in the murine caecum based on Ct values (Additional file 6:
Table S6). Moreover, miR-19b which was found to
have a 3.2-fold higher expression in the caecum versus the terminal ileum from biopsied samples in humans, was also found, based on our aforementioned
analysis, to be part of the 15 most highly expressed
miRNAs in the murine caecum (germ-free and conventional mice) but not within the jejunal or colonic
mucosa, suggesting this miRNA may exert a more
profound effect within the caecum. Although our
analysis of miRNA expression between intestinal regions in the mouse is qualitative and cannot be used
to determine fold differences in expression, it gives
merit into using the mouse as a model organism to
investigate intestinal miRNAs as certain parallels can
be found in humans.
The expression of these miRNAs may be under
genetic and environmental control. The latter is particularly important in the case of the intestine where
the epithelium engages in a continuous cross-talk
with the luminal microbes. Here we show that indeed
the endogenous microbiota contributes to the physiological miRNA signature in the caecum, which results in 16 miRNAs being differentially expressed
between germ-free and conventionally raised mice.
Moreover, of these, miR-133a and miR-467a were
found to be caecal specific miRNAs when compared
with the jejunum and colonic mucosa and miR-145
was a non-selectively expressed miRNA with high
levels of expression along the intestine, insinuating a
role for microbial control of both regional specific and
http://www.biolsci.org
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globally expressed miRNAs that may transcend the
boundaries of the caecum. Host miRNA modulation
has been so far observed in response to pathogenic
insults including prions [62], viruses such as Hepatitis
B and C [34] and influenza virus [63], bacteria such as
Helicobacter pylori [64], Francisella novicida [65] and
Gram negative bacteria LPS [66], the yeast Candida
albicans [67] or parasites such as Cryptosporidium parvum [68] and Toxoplasma gondii [69]. To our
knowledge, the only host-microbe symbiotic relationship associated to miRNA modulation in the host
is the legume-rhizobium symbiosis [39]. While we
used whole-thickness caeca, and therefore could not
establish the cellular origin of our measured signals, a
previous study revealed that at least nine human
miRNAs (hsa-miR-145, hsa-miR-150, hsa-miR-133a,
hsa-miR-148a,
hsa-miR-183,
hsa-let-7g*,
hsa-miR-181a*, hsa-miR-21*, hsa-miR-27b*) that have
sequence homology with our differentially expressed
murine miRNA are indeed expressed in colorectal cell
lines [24], suggesting that the intestinal epithelial
monolayer is susceptible of responding to the endogenous symbionts or their products, by miRNA
modulation.
To date limited information is available on the
biological role of these miRNAs; however, several of
the miRNAs found to be differentially expressed in
this study are known to be altered in cancer states.
miR-148a, which we found to be expressed more
highly in conventional mice, was found to be more
highly expressed in tumor samples versus normal
colonic epithelium [24], while miR-133a and miR-145,
which we found to be more highly expressed in
germ-free mice, were shown to exhibit significantly
higher levels of expression in normal versus tumor
tissues [70,71,72]. There is a general consensus in the
literature that endogenous gut microbes can alter colon cancer susceptibility and germ-free rats were
found to develop less and smaller tumors than their
conventional counterparts when using a protocol that
induces colorectal cancer [73]. This was attributed to
enhanced anticancer immune response. In our study,
a novel pathway may be proposed that incorporates
microbe signaling to the host and can alter the expression of tumor-suppressors or oncogenes
post-transcriptionally via miRNA regulation. Indeed,
miR-145 and miR-133a were both predicted by multiple algorithms to target Fascin-1 (FSCN1) (Figure 3), a
gene involved in actin cytoskeleton assembly, the
down-regulation of which was experimentally found
to explain the tumor suppressive effects of miR-145
and miR-133a in bladder, esophageal squamous cell
and breast carcinomas [71,74,75].
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However, inferring a microbiota-dependent
physiological role for differentially modulated miRNA species depends on the identification of their
mRNA targets in the caecum. Six of the endogenous
microbiota-dependent miRNAs were experimentally
proven in previous studies to target various genes,
some of which are expressed in the caecum. These
genes are categorized in various Gene Ontology classes including development, DNA binding, protein
binding, transcription as well as signaling pathways
including Wnt receptor signaling suggesting that the
microbiota may be an additional factor controlling
these functions. These findings are also in line with
our PANTHER analysis where experimentally validated targets that are co-expressed in the caecum also
map to some of the same functions of the targets predicted in silico.
Moreover, PANTHER, TargetScan and PITA
findings collectively reinforce the role that gut bacteria play in organization of the actin cytoskeleton and
gut angiogenesis, both previously shown to be affected by gut bacteria at the transcriptional (mRNA)
level [9,7,76] suggesting that the impact of gut bacteria
on specific pathways is many-sided. Particularly, in
terms of angiogenesis, global pathway analysis of
targets affected by the microbiota-dependent miRNAs
illustrate effects on angiogenesis including the process
of angiogenesis (p= 4.56E-13) itself and the Vascular
Endothelial Growth Factor (VEGF) signaling pathway
(p=7.67E-3). Although both the microbiota [76] and
miRNAs [77] have been independently shown to affect vascularization, in silico findings in this study
establish a possible link between them, and demonstrate a potential mechanism in which the molecular
dialogue between gut bacteria and the host is carried
out to affect these functions. Gut bacteria are important in the formation of the intestinal vascular
network during postnatal development [76] and
miRNAs in general are known to be developmentally
regulated. Since the gut microbiota gradually establishes during postnatal life, it is possible for the two
processes to intertwine. Indeed, a recent study
showed that exposure to LPS from endogenous E. coli
in the developing gut of the murine neonate, results in
toll-like receptor-4 mediated expression of miR-146a
and subsequent down-regulation of interleukin-1 receptor-associated kinase 1 (IRAK1) and the creation of
an immunologically tolerant environment [78]. Future
studies could examine the postnatal expression pattern of the differentially expressed miRNAs and of
their target genes.
Several studies have shown microbial dysbiosis
and miRNA deregulation to be important culprits in a
number of digestive diseases, including irritable
http://www.biolsci.org
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bowel syndrome [36,28] and ulcerative colitis [79,32].
Though, it is not understood if and how the two associate to impact these conditions. Based on our
findings, we suggest that deregulation of the microbial composition in digestive diseases may at least
partially affect the miRNA expression signature, and
in turn influence the associated pathologies. One line
of evidence involves miR-455, which in our study was
found to be up-regulated in the caecum of germ-free
mice, and found to target heat-shock factor 1 (hsf1)
based on bioinformatics analysis. Hsf1 attenuates the
effects of experimentally induced colitis in mice
models via indirectly inhibiting the production of
pro-inflammatory cytokines, cellular apoptosis and
cell adhesion molecule induction [80]. Although the
authors did not take into account both the microbiota
and miRNAs in these mice models we speculate that
altered microbial composition in these disease states
may affect miRNAs that in turn impact on hsf1 with
potential repercussions on gastrointestinal disease
states.
In both a healthy situation and disease state one
of the primary lines of defense in the gastrointestinal
tract is the intestinal barrier, of which the gut microbiota is a critical component. Though, at the same time
gut microbes act as a regulator of the barrier function
at the mRNA level, by impacting the expression of
several genes. Recently, genes regulating the intestinal barrier were found to be differentially expressed
in the jejunum of intestinal-specific Dicer knock-out
mice, highlighting a role for intestinal miRNAs in the
regulated expression of intestinal barrier genes [81]. In
line with this finding, we found that a number of
genes included in our intestinal barrier gene set are
indeed regulated post-transcriptionally in Dicer
knock-out mice and therefore depend on miRNAs.
Interestingly, these genes are also the potential targets
of gut microbiota-dependent miRNAs (Figure 3).
These were identified despite a stringent approach
excluding 376 of our intestinal barrier genes which are
not reported in the PITA and TargetScan databases.
Further supporting the existence of an intestinal barrier regulatory network involving miRNAs and the
gut microbiota, some of the intestinal barrier genes
targeted by our selected miRNAs were found to be
up- or down-regulated in Dicer 1-deficient mice versus controls [60], suggesting that the microbiota can
indirectly impact on the intestinal barrier
post-transcriptionally via miRNA regulation. Though,
it is important to note that in this study we used
whole thickness tissues in order to obtain a comprehensive evaluation of the intestinal miRNA signature
response to the commensals.
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Physiologically, the basis of this dialogue has yet
to be established; nonetheless, an emerging concept
incorporates the utilization of toll-like receptors
(TLRs) as potential mediators. For example, miR-147
was found to respond to LPS stimulation of TLR4 in
murine peritoneal macrophages, resulting in an attenuated release of Interleukin-6 (IL-6) and Tumour
Necrosis Factor alpha (TNF-α) [82]. Moreover,
miR-146a was also reported to dampen the inflammatory response upon up-regulation through PAMP
activated TLRs [83,33]. In turn, these studies show
applicability of microbial alterations in miRNA which
can impact the barrier function. Therefore, it seems
plausible that TLRs which are localized at the interface between the microbiota and the molecular machinery of host cells may be a potential facilitator of
this communication.
In summary, this study shows that the murine
caecum expresses a large variety of miRNAs, sixteen
of which exhibit differential expression in the presence or absence of the endogenous microbiota.
Therefore, gut bacteria may impact on intestinal gene
regulation not only at the transcriptional level but also
post-transcriptionally; thus, contributing to intestinal
homeostasis through fine-tuning gene expression. By
modulating miRNAs, the gut microbiota may affect a
much larger number of genes than so far expected,
particularly in a disease situation where the microbiota composition is altered towards less desirable species. In this perspective, abnormally expressed miRNAs could be considered novel therapeutic targets.
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